Pickrell, William O. and Robertson, Neil P.
2018.
New treatments in Alzheimer's disease.
Journal of Neurology
265
(9)
, pp. 2162-2163.
10.1007/s00415-018-9018-1
![]() |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (535kB) | Preview |
Abstract
Alzheimer’s disease is the most common cause of dementia, affecting around 50 million people worldwide. Its prevalence is increasing mainly as a result of an ageing population with considerable associated increases in health and social care costs. As a result, government agencies worldwide have turned funding streams towards unravelling biological mechanisms and developing therapeutic opportunities for the dementias in general. Consequently, a number of novel potential treatments have been developed, although, to date, they have not been shown to significantly alter disease course. In this month’s journal club we look at three large clinical trials of new treatments in Alzheimer’s disease.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) |
Publisher: | Springer |
ISSN: | 0340-5354 |
Date of First Compliant Deposit: | 18 September 2018 |
Date of Acceptance: | 31 July 2018 |
Last Modified: | 25 Feb 2019 11:40 |
URI: | https://orca.cardiff.ac.uk/id/eprint/115036 |
Citation Data
Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |